News and Press Releases

BioFIT 2023: The leading European partnering event in Life Sciences is back in Marseille

BioFIT, the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field, is set to take place on December 12th and 13th, 2023 in Marseille,...

Category: Drug Discovery, Other, Pharmaceutical
Posted: November 16, 2023

Parc Chanot 114. Rond-Point du Prado 13008 Marseille FRANCE

LATAM group receives its 19th cargo aircraft, increasing its freighter capacity by over 70% compared to 2019

The growth strategy announced in 2021  for LATAM group's cargo operators, included the addition of eight B767 passenger aircraft converted into cargo planes. With this latest addition, the group reinforces...

Category: Logistics
Posted: November 14, 2023

Vetter’s European clinical site receives permanent Manufacturer’s Authorisation

Successful inspection completed at clinical site Inspectors were impressed with systems and processes Austrian site supports manufacturing and quality control of Human Investigational Medicinal Products 9 November 2023 – Ravensburg,...

Category: Logistics, Manufacturing and Packing
Posted: November 10, 2023

Schützenstrasse 87, 88212 Ravensburg

Tower announces the ‘Evolution’ of the pharmaceutical cold chain

The latest innovation from Tower Cold Chain, a pioneer in passive temperature-controlled containers, offers pharmaceutical manufacturers, airlines and 3PL providers a single solution compatible with US and EU pallets –...

Category: Logistics, Manufacturing and Packing
Posted: November 3, 2023

Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK

Dr Björn Beckmann Appointed Head of Quality Control at Rentschler Biopharma’s Laupheim Site

31 October 2023 – Laupheim, Germany – Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today announced that Dr Björn Beckmann has been promoted...

Category: BioManufacturing, Drug Delivery, Drug Discovery
Posted: October 31, 2023

Erwin-Rentschler-Str. 21 88471 Laupheim Germany

Cytomos selected to showcase CDS cell analysis technology at BIA’s BioProcessUK Dragon’s Den session

23 October 2023 – Biotech company, Cytomos (www.cytomotos.com) is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcessUK Dragon’s Den...

Category:
Posted: October 30, 2023

Middle Wing Building University of Edinburgh Easter Bush Campus Roslin EH25 9RG Scotland

Phastar Offers Pro Bono Support to Medicines Development for Global Health

Supporting medicine development for disadvantaged communities 26th October 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), is offering pro bono support to...

Category: Other
Posted: October 30, 2023

Unit 2, 2A Bollo Ln, Chiswick, London W4 5LE

Optibrium introduces cloud-based version of StarDrop drug discovery platform

Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium recently received ISO 27001 accreditation...

Category: Drug Delivery, Drug Discovery
Posted: October 27, 2023

Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK

Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology

REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packaging size in various tissues Potential to address prevalent inherited diseases caused...

Category:
Posted: October 27, 2023

ViGeneron GmbH, Semmelweisstraße 3, 82152, Planegg, Germany

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics

myNEO Therapeutics to focus on building proprietary product pipeline based on a novel class of shared therapeutic cancer targets derived from the dark genome named “camyotopes” Lead product CAMYO-01 incorporates...

Category: BioManufacturing, Drug Delivery
Posted: October 27, 2023

Ottergemsesteenweg 439 9000 Ghent Belgium

Commercial study set up times reduced by a third, according to new data 

26 October 2023 -- London, England -- New data from the National Institute for Health and Care Research (NIHR) shows that the National Contract Value Review has significantly reduced the...

Category: Clinical Trials
Posted: October 26, 2023

Cambridge Cognition launches AQUA to automate quality assurance in CNS trials using speech analysis

25 October 2023 -- Cambridge, UK -- Cambridge Cognition, a leader in digital health solutions for brain health assessment, announces the launch of AQUA, an automated quality assurance solution for...

Category: Clinical Trials
Posted: October 26, 2023

Cambridge Cognition Tunbridge Court Bottisham Cambridge CB25 9TU

Newly established 3PARL consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits

Rephine and Eurofins Healthcare are acting against substandard audit practices with guarantees of the highest quality of inspection services & library reports, from raw materials to finished products 24 October...

Category: Other
Posted: October 25, 2023

15, Meadway Court, Rutherford Cl, Stevenage SG1 2EF

Roquette completes the acquisition of Qualicaps and reinforces its global position in the pharmaceutical industry

This strategic investment creates a stronger leader, with an expanded global footprint, as well as an enriched offering of oral dosage solutions. 24 October 2023 -- La Madeleine, France, and...

Category: Drug Delivery, Manufacturing and Packing
Posted: October 24, 2023

1 rue de la Haute Loge, 62136 Lestrem France

Landmark Phase 3 MARIPOSA Study Shows RYBREVANT▼(amivantamab) Plus Lazertinib Resulted in 30% Reduction in Risk of Disease Progression or Death Compared to Osimertinib in Patients with EGFR-Mutated NSCLC

Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in patients with and without brain metastases Late-breaking results from...

Category: Clinical Trials
Posted: October 24, 2023

Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG